Internal Medicine, Endocrinology, Diabetes, & Metabolism · Tampa, FL
NPI
1144595406
Since 2012
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
602 S Audubon Ave Ste A
Tampa, FL, 33609
Phone (813) 931-2424
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
122 services
Medicare patients, 2024
51
Average age 68
Drug cost, 2024
$1.5M
848 prescriptions
Company payments, 2025
$1,319
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Madeline Candelario-Cosme was code 99215 (office e&m - established), 39 times for 24 patients. In total Madeline Candelario-Cosme billed 122 services in 15 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 39 | 24 | $133.05 | $5,189 |
| 99204 Office E&M - New | Office | 19 | 19 | $130.41 | $2,478 |
By year: 2022 $37K for 406 services; 2023 $33K for 385 services; 2024 $12K for 122 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 53 | 42 | $9.52 | $505 |
Medicare prescription drug claims, 2024
In 2024, the drug Madeline Candelario-Cosme prescribed most often to Medicare patients was Levothyroxine Sodium, with 66 prescriptions and refills. In total Madeline Candelario-Cosme wrote 848 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 66 | 162 | 25 | $712 |
| Ozempic Semaglutide | 54 | 79 | 16 | $68K |
| Jardiance Empagliflozin | 45 | 87 | 16 | $51K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 41 | 93 | 19 | $7,908 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 27 | 32 | Under 11 | $2,066 |
| Novolog Flexpen Insulin Aspart | 27 | 50 | 15 | $8,089 |
| Hydrocortisone Generic | 27 | 45 | Under 11 | $2,329 |
| Trulicity Dulaglutide | 26 | 40 | Under 11 | $40K |
| Januvia Sitagliptin Phosphate | 25 | 38 | Under 11 | $22K |
| Metformin Hcl Generic | 24 | 52 | Under 11 | $106 |
| Isturisa Osilodrostat Phosphate | 24 | 24 | Under 11 | $1.1M |
| Synthroid Levothyroxine Sodium | 22 | 49 | 11 | $2,238 |
| Humalog Insulin Lispro | 22 | 30 | Under 11 | $3,398 |
| Cabergoline Generic | 19 | 27 | Under 11 | $1,249 |
| Mounjaro Tirzepatide | 19 | 36 | 11 | $40K |
Brand drugs: 494 claims; generic drugs: 258 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Madeline Candelario-Cosme $1,319 ($1,319 in general payments such as food, travel and fees) from 22 companies. The largest payer was Novo Nordisk Inc with $267.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 17 | $267 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $190 |
| Amgen Inc. AMGN | 6 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $94.48 |
| Xeris Pharmaceuticals, Inc. | 4 | $85.82 |
| Lilly USA, LLC LLY | 4 | $85.43 |
| Sequel Med Tech, LLC | 3 | $75.3 |
| Dexcom, Inc. DXCM | 2 | $55.29 |
| Almatica Pharma LLC | 2 | $42.04 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.